Stephanie Graff named director of breast oncology at Lifespan Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Stephanie Graff was named director of breast oncology at the Lifespan Cancer Institute.

Graff is board certified in medical oncology, hematology, and internal medicine. 

Graff comes to Lifespan from the Sarah Cannon Cancer Center of HCA Healthcare, where she was director of the breast program for HCA Midwest in Kansas City and both the National Breast Lead and Associate Director of Breast Cancer Research for the entire Sarah Cannon network.

She is the medical director of the Dr. Susan Love Foundation for Breast Cancer Research. 

Table of Contents

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login